Saturday 17 October 2026
Export BMEA’s income statement to Excel — free account
Biomea Fusion, Inc.
BMEA Healthcare Biotechnology
In the quarter to June 2026, EPS grew 76.5% and free cash flow grew 47.8%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
0.87
0.03
+3.57%
Follow BMEA
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Current Ratio |
+8 more quarters Free account |
3.18 | 5.23 | 4.98 | 3.48 |
Net Debt/EBITDA |
2.29 | 4.78 | 3.54 | 2.76 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.70 | (3.02) | 0.94 | 1.20 | |
Capex/Depreciation |
0.00 | 0.00 | 11.96 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.19) | (0.27) | (0.15) | (0.14) | |
Cash per Share |
0.78 | 1.07 | 0.62 | 0.49 | |
Shareholders Equity per Share |
0.26 | 0.57 | 0.26 | 0.17 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.26 | 0.57 | 0.26 | 0.17 | |
Free Cash Flow |
(11.55) | (13.94) | (11.12) | (10.03) | |
Working Capital |
33.88 | 46.95 | 37.02 | 25.95 | |
Capital Expenditures |
— | — | 0.55 | 0.00 | |
Net Current Asset Value |
9.87 | 29.03 | 18.65 | 11.69 | |
| Other line items | |||||
Quick Ratio |
3.00 | 5.03 | 4.85 | 3.36 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.19) | (0.27) | (0.16) | (0.14) | |
Capex per Share |
0.00 | 0.00 | 0.01 | 0.00 | |
Average Payables |
7.69 | 8.08 | 6.16 | 5.84 | |
Average Assets |
82.80 | 69.26 | 50.72 | 55.02 | |
Average Common Equity |
45.80 | 40.56 | 23.73 | 19.82 | |
Capex to Sales |
— | — | 0.00 | 0.00 |
Columns are period end dates